📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
NGL Fine-Chem Credit Rating Outlook Upgraded to 'Stable' from 'Negative'
CRISIL Ratings has revised the outlook on NGL Fine-Chem Limited's long-term bank loan facilities to 'Stable' from 'Negative'. While the outlook has improved, the long-term rating itself has been reaffirmed at 'CRISIL BBB+'. Additionally, the company's short-term rating was reaffirmed at 'CRISIL A2'. This revision indicates a stabilization in the company's credit profile and a reduced risk of a rating downgrade in the near term.
Key Highlights
Outlook on long-term bank facilities revised to 'Stable' from 'Negative'
Long-term credit rating reaffirmed at 'CRISIL BBB+'
Short-term credit rating reaffirmed at 'CRISIL A2'
Rating action communicated by CRISIL Ratings on March 12, 2026
💼 Action for Investors
Investors should view the outlook upgrade as a sign of improving financial stability; however, continue to monitor quarterly earnings for sustained operational growth.
NGL Fine-Chem Q3FY26 PAT Jumps 1129% YoY to ₹15.69 Cr; EBITDA Margin Hits 17.5%
NGL Fine-Chem reported a robust Q3FY26 with revenue growing 43.11% YoY to ₹127.51 crore, driven by higher volumes and stable realizations. Profitability saw a massive jump, with PAT rising over 11-fold to ₹15.69 crore and EBITDA margins expanding to 17.50% from 5.72% a year ago. The company's major greenfield expansion at Tarapur is on track with a revised investment of ₹210 crore, targeting commissioning in Q1FY27. Management expects commercial production from this facility to start in H2FY27, aiming for an asset turnover of over two times.
Key Highlights
Revenue from operations grew 43.11% YoY to ₹127.51 crore in Q3FY26.
EBITDA margin improved significantly to 17.50% compared to 5.72% in the previous year's quarter.
Animal API remains the core segment, contributing 92% of the total revenue mix.
Greenfield expansion project cost revised to ₹210 crore with ₹156 crore already invested; commissioning expected in Q1FY27.
Debt for the expansion project is capped at ₹85 crore, with the remainder funded via internal accruals.
💼 Action for Investors
Investors should note the significant margin recovery and the upcoming capacity expansion which could drive the next leg of growth. Monitor the commissioning of the Tarapur facility in Q1FY27 and the subsequent ramp-up in H2FY27.
NGL Fine-Chem Q3 PAT Surges to ₹15.69 Cr; Revenue Up 43% YoY
NGL Fine-Chem reported a stellar performance for Q3 FY26, with consolidated net profit jumping to ₹15.69 crore from just ₹1.28 crore in the same quarter last year. Revenue from operations grew by 43.1% YoY to ₹127.51 crore, reflecting strong operational recovery. For the nine-month period ending December 2025, the company has already surpassed its full-year FY25 profit, reaching ₹34.56 crore. Additionally, the company appointed Shivam Gharat as the new Company Secretary and Compliance Officer.
Key Highlights
Consolidated Net Profit rose exponentially to ₹15.69 crore in Q3 FY26 from ₹1.28 crore in Q3 FY25.
Revenue from operations increased 43.1% YoY to ₹127.51 crore compared to ₹89.10 crore in the previous year.
Basic EPS saw a massive jump to ₹25.40 in Q3 FY26 from ₹2.07 in the year-ago period.
Nine-month consolidated PAT stands at ₹34.56 crore, significantly higher than the ₹20.31 crore reported in the same period last year.
Shivam Gharat appointed as Company Secretary and Compliance Officer effective February 3, 2026.
💼 Action for Investors
The company is showing strong growth momentum with nine-month profits already exceeding the previous full year's performance. Investors should maintain a positive outlook while monitoring the impact of new labour code regulations on future employee benefit costs.
NGL Fine-Chem Q3 PAT Surges 1129% YoY to ₹15.69 Cr; Revenue Up 43%
NGL Fine-Chem reported a stellar performance for the quarter ended December 31, 2025, with consolidated revenue growing 43% YoY to ₹127.51 crore. The net profit saw an exponential jump of 1129% YoY, reaching ₹15.69 crore compared to ₹1.28 crore in the same quarter last year. On a sequential basis, profits grew by 63%, driven by significantly improved operating margins and higher other income. The company also announced the appointment of Shivam Gharat as the new Company Secretary and Compliance Officer.
Key Highlights
Consolidated Revenue from Operations increased 43.1% YoY to ₹12,750.99 lakhs.
Net Profit (PAT) skyrocketed to ₹1,569.07 lakhs from ₹127.66 lakhs in the previous year's corresponding quarter.
Earnings Per Share (EPS) improved significantly to ₹25.40 from ₹2.07 YoY.
Profit Before Tax (PBT) margins expanded to 16.2% in Q3 FY26 compared to 1.4% in Q3 FY25.
Nine-month (9M) PAT stands at ₹34.56 crore, already surpassing the full FY25 PAT of ₹21.12 crore.
💼 Action for Investors
The stock is expected to react very positively to this massive turnaround in profitability and margin expansion. Investors should hold the stock while monitoring the sustainability of these high margins in future quarters.
NGL Fine-Chem Q3 PAT Surges 1129% YoY to ₹15.69 Cr; Revenue Up 43%
NGL Fine-Chem reported a stellar performance for Q3 FY26, with consolidated revenue growing 43% YoY to ₹127.51 crore. The net profit witnessed a massive jump of 1129% YoY, reaching ₹15.69 crore compared to ₹1.28 crore in the same quarter last year. On a sequential basis, profits rose by 63%, indicating strong operational momentum. The company also announced the appointment of Shivam Gharat as the new Company Secretary and Compliance Officer.
Key Highlights
Consolidated Revenue from Operations rose 43.1% YoY to ₹12,750.99 lakhs.
Net Profit (PAT) skyrocketed to ₹1,569.07 lakhs from ₹127.66 lakhs in the previous year's corresponding quarter.
Profit Before Tax (PBT) for the quarter stood at ₹2,066.99 lakhs, a significant jump from ₹126.53 lakhs YoY.
Nine-month (9M FY26) PAT reached ₹3,455.67 lakhs, already exceeding the full FY25 PAT of ₹2,112.43 lakhs.
Basic EPS for the quarter increased to ₹25.40 from ₹2.07 in Q3 FY25.
💼 Action for Investors
The stock is expected to react very positively to this massive turnaround in profitability and robust revenue growth. Investors should hold the stock while monitoring the sustainability of these high margins in future quarters.